Brief: PMV Pharmaceuticals Q3 EPS USD -0.34
09/11/2023 13:00
Nov 09 (Reuters) - PMV Pharmaceuticals Q3 net income USD -16.64 million. * Q3 operating income USD -19.628 million * Q3 operating expenses USD 19.628 million
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics